Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous zoledronic acid for stress fractures of the foot
2014-004318-27Phase 4Terminated
- Sponsor
- Oslo University Hospital
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of zoledronic acid in stress fracture of the foot, sponsored by Oslo University Hospital. Primary endpoint: Change in AOFAS ankle-hindfoot scale. Started May 2016; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
stress fracture of the foot
Beyond the preview
Go deeper on 2014-004318-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004318-27.